Lupus Nephritis (LN): Global Growth Opportunities & Epidemiology Forecast to 2028 - ResearchAndMarkets.com

DUBLIN--()--The "Lupus Nephritis (LN) - Epidemiology Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

This report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Lupus Nephritis in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Japan

Lupus Nephritis Epidemiology

The Lupus Nephritis (LN) epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. The epidemiology data for Lupus Nephritis are studied through all possible division to give a better understanding about the Disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Lupus Nephritis Epidemiology Segmentation

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (total prevalent cases, gender-specific prevalent cases, class-specific prevalent cases, clinical manifestations and diagnosed cases of LN) scenario of Lupus Nephritis (LN) in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2017-2028.

The report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

The total number of prevalent cases of Lupus Nephritis (LN) in 7 MM was found to be 190,819 in the year 2017.

Report Scope

  • The report covers detailed overview of Lupus Nephritis explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The report provides the insight about the historical and forecasted patient pool of Lupus Nephritis in 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Report assesses the disease risk and burden and highlights the unmet needs of the disease
  • The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report provides the segmentation of the disease epidemiology by prevalence of LN, gender based prevalence, class based prevalent cases, clinical manifestations and diagnosed cases in 7MM

Key Strengths

  • 10 Year Forecast of Lupus Nephritis epidemiology
  • 7MM Coverage
  • Total Prevalent Cases of LN
  • Prevalent Cases according to segmentation: Prevalence, Types, Class Based, Clinical Manifestations and segments based gender
  • Diagnosed cases of LN

Key Assessments

  • Patient Segmentation
  • Disease Risk & Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Key Topics Covered

1. Key Insights

2. Lupus Nephritis: Market Overview at a Glance

2.1. Total Market Share (%) Distribution of Lupus Nephritis in 2017

2.2. Total Market Share (%) Distribution of Lupus Nephritis in 2028

3. Lupus Nephritis: Disease Background and Overview

3.1. Introduction

3.2. Causes

3.3. Risk Factors

3.4. Symptoms

3.5. Other Clinical Manifestation

3.6. Prognosis of lupus nephritis

3.7. Clinical presentation of lupus nephritis

3.8. Pathogenesis

3.9. Classification

3.9.1. LN World Health Organization 1964 Classification

3.9.2. LN World Health Organization 1964 Classification

3.9.3. World Health Organization (WHO) morphologic classification of lupus nephritis (modified in 1982)

3.9.4. LN World Health Organization 1964 Classification

3.9.5. International Society of Nephrology (ISN) and Renal Pathology Society (RPS) 2003 Classification for LN

3.9.6. LN World Health Organization 1964 Classification

3.10. Diagnosis

4. Epidemiology and Patient Population

4.1. Key Findings

5. 7MM Total Prevalent Patient Population of LN

6. Country Wise-Epidemiology of Lupus Nephritis

6.1. United States

6.1.1. Assumptions & Rationale

6.1.2. Total Prevalent Population of Lupus Nephritis

6.1.3. Total Diagnosed Population of Lupus Nephritis

6.1.4. Gender-Specific Prevalent Population of Lupus Nephritis

6.1.5. Class-Specific Cases of Lupus Nephritis

6.1.6. Clinical Manifestations of Lupus Nephritis

6.2. EU5 Countries

6.3. Germany

6.4. France

6.5. Italy

6.6. United Kingdom

6.7. Spain

6.8. Japan

7. Appendix

7.1. Report Methodology

8. Capabilities

For more information about this report visit https://www.researchandmarkets.com/r/glr7pt

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900